Search Results - "Moro, Ana M."

Structural Changes in Stx1 Engineering Monoclonal Antibody Improves Its Functionality as Diagnostic Tool for a Rapid Latex Agglutination Test by Luz, Daniela, Shiga, Emerson, Chen, Gang, Quintilio, Wagner, Andrade, Fernanda, Maranhão, Andrea, Caetano, Bruna, Mitsunari, Thaís, Silva, Míriam, Rocha, Letícia, Moro, Ana, Sidhu, Sachdev, Piazza, Roxane

“…Stx1 toxin is one of the AB5 toxins of Shiga toxin-producing Escherichia coli (STEC) responsible for foodborne intoxication during outbreaks. The single-chain…”
Get full text

Radiolabeled nano-peptides show specificity for an animal model of human PC3 prostate cancer cells by Faintuch, Bluma Linkowski, Núñez, Gustavo Eutimio Fernández, Teodoro, Rodrigo, Moro, Ana M, Mengatti, Jair

“…Cancer has been investigated using various pre-targeting techniques or models focusing on radiobombesin analogues; however, both are not offered together. In…”
Get full text

Analysis of the ‘Evaluation Indicators’ of an Enhanced Recovery After Bariatric Surgery Pathway in the First Six Months After Implementation by Gimeno-Moro, Ana M., Errando, Carlos L., Escrig-Sos, Vicente J., Laguna-Sastre, José M.

“…The implementation of a clinical pathway in bariatric surgery (BS) might facilitate systemic care. Focusing on enhanced recovery after surgery (ERAS) programs…”
Get full text

Comparison of two peptide radiotracers for prostate carcinoma targeting by Faintuch, Bluma Linkowski, Oliveira, Erica A, Nunez, Eutimio G F, Moro, Ana M, Nanda, P K, Smith, Charles J

“…Scintigraphy is generally not the first choice treatment for prostate cancer, although successful studies using bombesin analog radiopeptides have been…”
Get full text

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma by Smaletz, Oren, Diz, Maria D.P.E, do Carmo, Claudio C, Sabbaga, Jorge, Cunha-Junior, Geraldo F, Azevedo, Sergio J, Maluf, Fernando C, Barrios, Carlos H, Costa, Ronaldo L, Fontana, Ana G, Madrigal, Vivian, Wainstein, Alberto J, Yeda, Fernanda P, Alves, Venâncio A, Moro, Ana M, Blasbalg, Roberto, Scott, Andrew M, Hoffman, Eric W

“…Abstract Objectives The primary objective was to evaluate the clinical efficacy of hu3S193, a humanized monoclonal antibody against the Lewis-Y antigen, in…”
Get full text

Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells by Silva, Hernandez M, Vieira, Pedro M.M.M, Costa, Patricia L.N, Pimentel, Bárbara M.S, Moro, Ana M, Kalil, Jorge, Maranhão, Andrea Q, Coelho, Verônica, Brigido, Marcelo M

“…Abstract Strategies to minimize the immunogenicity and toxicity of murine anti-CD3 antibodies (e.g. OKT3) are of special interest for organ transplantation and…”
Get full text

Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres by Namur, Jocimara A.M., Takata, Célia S., Moro, Ana M., Politi, Mário J., de Araujo, P.Soares, Cuccovia, Iolanda M., da Costa, M.H.Bueno

“…Microspheres of polymers like poly(lactic-co-glycolic acid) (PLGA) have been studied as a vehicle for controlled release vaccines. They require materials and…”
Get full text

Anti-LeY monoclonal antibody (mAb) hu3S193 as consolidation therapy for patients (pts) with relapsing platinum sensitive ovarian cancer (OC) after achieving a second complete response (2CR) by Smaletz, Oren, Ismael, Gustavo, Estevez-Diz, Maria Del Pilar, Nascimento, Ivana Lucia Oliveira, Wiermann, Ana Luiza Gomes de Morais, Cunha, Geraldo Felicio, Azevedo, Sergio J, Alves, Venâncio A, Moro, Ana M, Yeda, Fernanda Perez, dos Santos, Mariana Lopes, Majumder, Indrani, Hoffman, Eric W.

“…Abstract only e17039 Background: Lewis-Y (LeY) antigen is a blood group related antigen expressed in 75% of OC. hu3S193 is a humanized anti-LeY IgG1 mAb with…”
Get full text

Strategies for clone detection, selection and isolation in Per.C6 cells - case for Rebmab100 by Yeda, Fernanda P, dos Santos, Mariana L, Tsuruta, Lilian R, Horta, Bruno B, Inocencio, André L, Okamoto, Oswaldo K, Tuma, Maria C, Moro, Ana M

“…Doc number: P38…”
Get full text

Bispecific monoclonal antibody anti-CD3 x anti-tenascin: an immunotherapeutic agent for human glioma by Davico Bonino, L, De Monte, L B, Spagnoli, G C, Vola, R, Mariani, M, Barone, D, Moro, A M, Riva, P, Nicotra, M R, Natali, P G

“…Besides surgery, the therapeutic possibilities for the treatment of human gliomas include adoptive cellular immunotherapy, radioimmunotherapy, immunotherapy…”
Get more information

Is there a sex-phenotype association for esterase D (EC 3.1.1.1)? by Moro-Furlani, A M, Cabello, P H, Krieger, H

“…Recently, a significant sex distortion of the esterase D locus segregation, both in Portugal and Germany, was reported. In contrast to these puzzling results,…”
Get more information